Last time you posted BLH you said INCY didn't have one approved drug? That wasn't the case...they have one very good one and a host of bullets in their holster. In this Industry that's a very good thing and one that others look at very closely. ONXX has "one" approved drug and fetched a hefty sum from AMGEN. INCY gets anymore to market and look out!
There are not very many small biotechs with an approved drug plus another in late stage 3 plus several other drugs in the pipe! This is a $10 bil MC it's not over valued unless INCY is happy where they are and sitting on their hands! If you look at what they spend in R&D you will have to admit that they are not sitting on their hands! When more data comes in this year this stock will be significantly higher and when Bari is approved look out! I think we could be triple digits before too long!